Live Cell Imaging Market based on Product (Equipment, Consumable and Software), Application (Cell Biology, Developmental Biology, Stem Cell & Drug Discovery and Others), Technology (Time-lapse Microscopy, Fluorescence recovery after photobleaching (FRAP), Fluorescence resonance energy transfer (FRET), High content screening (HCS) and Others) and Geography – Global Forecast up to 2027

Live Cell Imaging Market Statistics 2027

The Live Cell Imaging Market is anticipated to grow at the rate of 8.9% CAGR by 2027. Key drivers of the live cell imaging market include growing adoption in a variety of cell biology labs and the rising use of High-Content Screening(HCS) approaches in the development of drugs. Further, an increase in drug discovery efforts and growing government investment in cell-based research around the globe is expected to spur the growth of the live cell imaging market in the coming years. Moreover, growing cancer awareness is also expected to drive the growth of the market during the forecast period. 

Trends Influencing the Global Live Cell Imaging Market

Growing adoption in cell biology labs and rising High Content Screening approach (HCS)

Live-cell imaging has transformed the way researchers, biologists study protein, cells, and molecular interactions. Live imaging techniques allow observation of cellular processes and molecular structures in real-time which is crucial for studying cell biology. It also balances the environmental factors maintaining cell health and viability providing more reliable information than fixed cell microscopy. On the other hand, the High Content Screening (HCS) approach is finding extensive usage in drug discovery processes making use of live-cell imaging to extract useful data. HCS technology is integrated into every aspect of drug development such as primary, post-primary screening, drug profiling, determining toxicity and absorption properties, etc. HCS is time and cost-efficient. Thus widescale adoption in cell biology labs and growing HCS usage in drug development will drive the growth of the live cell imaging market during the forecast period.

Increasing drug discovery efforts and rising investments in cell-based research

Live imaging techniques in drug creation give researchers a complete picture of therapeutic pharmacology allowing for accurate clinical response predictions. It can monitor internal cell structures, dynamic biological processes and collect a wealth of cellular data in real-time providing an accurate investigation of fast kinetic events and conducting long-term time-lapse investigations. Moreover growing government funding on cell-based research and medicinal studies will also affect the market growth. Thus increasing usage of live imaging in drug discovery efforts and rising government funding in cell-based research is expected to propel the growth of the live cell imaging market during the forecast period.

Growing cancer awareness and research

Cancer cells are studied via live cell imaging to detect abnormal growth at the cellular level. Live imaging can look through cellular integrity, enzyme activity, protein trafficking, exocytosis and endocytosis etc in order to provide a more valuable real time data. Further government around the world are funding research on detecting cancer and other disorders at the cellular level. Thus growing cancer awareness and research will boost the growth of the live cell imaging market during the forecast period.

Live Cell Imaging Market Share Analysis

Based on product, the equipment segment is expected to provide lucrative opportunities for growth in the live cell imaging market share as growing research is being carried out to develop microscopes of higher resolution. In addition to it advanced technologies such as inverted research grade microscopes have enabled imaging of adherent cells, organelles to produce tissues sections of less than 5 um thickness. They are also enabling imaging of cells in spatial resolutions.

Based on application, the cell biology segment is expected to provide lucrative opportunities for growth in the live cell imaging market share during the forecast period due to growing number of researchers working on molecular interaction networks and advanced filter techniques , illumination devices further enabling the process.

Based on technology, the fluorescence resonance energy transfer segment wil provide lucrative opportunities for growth in the live cell imaging market share due to its increasing usage in genetic targeting peptides and advantage offered in determining the spatial proximity at protein level which fluorescence microscopy cannot obtain.

Based on region, North America is expected to provide lucrative opportunities for growth in the live cell imaging market share due to growing usage of live cell imaging for drug discovery and increasing number of products launched by manufacturers in the region. 

Live Cell Imaging Market Segmentation

Live Cell Imaging Market by Product

• Equipment
• Consumable
• Software.

Based on the product, the equipment segment has dominated the market. However, immense researchbeing carried out to develop microscopes of higher resolution is likely to boost the segment growth. Advanced technologies such as inverted research-grade microscopes have allowed imaging of adherent cells and organelles and produce outcomes for tissue sections of less than 5 um thickness. Advanced developments are also enabling imaging of the cells in spatial resolutions within a time range.

Live Cell Imaging Market by Application

• Cell Biology
• Developmental Biology
• Stem Cell & Drug Discovery
• Others.

The cell biology segment is leading the market on the basis of application. This is due to the increasing number of researchers working on molecular interaction networks. In addition, filter techniques and advanced illumination devices are innovations that further allow the procedure. Moreover, cell biologists use live cell imaging to understand the basic cellular structures and their interaction on the tissue level.

Live Cell Imaging Market by Technology

• Time-lapse Microscopy
• Fluorescence recovery after photobleaching (FRAP)
• Fluorescence resonance energy transfer (FRET)
• High content screening (HCS)
• Others.

Further, the fluorescence resonance energy transfer segment is the significant segment based on the technology in the market. This is due to its advantage in ascertaining the spatial proximity at the protein level, which fluorescence microscopy cannot obtain. Furthermore, this technology has gained popularity in recent years due to its increasing application in genetic targeting peptides.

Live Cell Imaging Market by Region

• North America
• Europe
• Asia Pacific
• Rest of the World 

Leading Vendors of the Live Cell Imaging Market are: 

• Thermo Fisher Scientific Inc.,
• Nikon Instruments Inc.,
• Molecular Devices, LLC,
• BioTek Instruments, Inc.,
• PerkinElmer Inc.,
• Bruker Corporation,
• General Electric,
• Olympus Corporation,
• CYTOSKELETON, INC.
• Merck KGaA.

Henceforth, live cell imaging technology has changed the way biologists study cells, proteins, and various processes and molecular interactions. Moreover, live cell imaging technology is majorly helpful in cell biology, which is a key concept in understanding the functions of cells.

• This report identifies the regions and segments projected to witness the highest CAGR rate and lead the market.
• The report also provides the analysis of geography focusing on the consumption of the product/service in the region coupled with the factors impacting the market in each region.
• This report gives the competitive outlook, which consists of the market ranking of the key players.
• Further present the information of recent product launches, partnerships, business expansions, and acquisitions of the market vendors.

Scope of Live Cell Imaging Market Report

Frequently Asked Questions About This Report

1. Executive Summary
2. Industry Outlook
   1. Industry Overview
   2. Industry Trends
3. Market Snapshot
   1. Market Definition
   2. Market Outlook
      1. Porter Five Forces
   3. Related Markets
4. Market characteristics
   1. Market Overview
   2. Market Segmentation
   3. Market Dynamics
      1. Drivers
      2. Restraints
      3. Opportunities
   4. DRO - Impact Analysis
5. Product: Market Size & Analysis
   1. Overview
   2. Equipment
   3. Consumable
   4. Software
6. Application: Market Size & Analysis
   1. Overview
   2. Cell Biology
   3. Developmental Biology
   4. Stem Cell & Drug Discovery
   5. Others
7. Technology: Market Size & Analysis
   1. Overview
   2. Time-lapse Microscopy
   3. Fluorescence recovery after photobleaching (FRAP)
   4. Fluorescence resonance energy transfer (FRET)
   5. High content screening (HCS)
   6. Others
8. Geography: Market Size & Analysis
   1. Overview
   2. North America
   3. Europe
   4. Asia Pacific
   5. Rest of the World
9. Competitive Landscape
   1. Competitor Comparison Analysis
   2. Market Developments
      1. Mergers and Acquisitions, Legal, Awards, Partnerships
      2. Product Launches and execution
10. Vendor Profiles
    1. Thermo Fisher Scientific Inc.
       1. Overview
       2. Financial Overview
       3. Product Offerings
       4. Developments
       5. Business Strategy
    2. Nikon Instruments Inc.
       1. Overview
       2. Financial Overview
       3. Product Offerings
       4. Developments
       5. Business Strategy
    3. Molecular Devices, LLC
       1. Overview
       2. Financial Overview
       3. Product Offerings
       4. Developments
       5. Business Strategy
    4. BioTek Instruments, Inc.
       1. Overview
       2. Financial Overview
       3. Product Offerings
       4. Developments
       5. Business Strategy
    5. PerkinElmer Inc.
       1. Overview
       2. Financial Overview
       3. Product Offerings
       4. Developments
       5. Business Strategy
    6. Bruker Corporation
       1. Overview
       2. Financial Overview
       3. Product Offerings
       4. Developments
       5. Business Strategy
    7. General Electric
       1. Overview
       2. Financial Overview
       3. Product Offerings
       4. Developments
       5. Business Strategy
    8. Olympus Corporation
       1. Overview
       2. Financial Overview
       3. Product Offerings
       4. Developments
       5. Business Strategy
    9. CYTOSKELETON, INC.
       1. Overview
       2. Financial Overview
       3. Product Offerings
       4. Developments
       5. Business Strategy
    10. Merck KGaA
        1. Overview
        2. Financial Overview
        3. Product Offerings
        4. Developments
        5. Business Strategy
11. Annexure
    1. Report Scope
    2. Market Definitions
    3. Research Methodology
       1. Data Collation and In-house Estimation
       2. Market Triangulation
       3. Forecasting
    4. Report Assumptions
    5. Declarations
    6. Stakeholders
    7. Abbreviations

TABLE 1.           GLOBAL LIVE CELL IMAGING MARKET VALUE, BY PRODUCT, 2021-2027 (USD BILLION)

TABLE 2.           GLOBAL LIVE CELL IMAGING MARKET VALUE FOR EQUIPMENT, BY GEOGRAPHY, 2021-2027 (USD BILLION)

TABLE 3.           GLOBAL LIVE CELL IMAGING MARKET VALUE FOR CONSUMABLE, BY GEOGRAPHY, 2021-2027 (USD BILLION)

TABLE 4.           GLOBAL LIVE CELL IMAGING MARKET VALUE FOR SOFTWARE, BY GEOGRAPHY, 2021-2027 (USD BILLION)

TABLE 5.           GLOBAL LIVE CELL IMAGING MARKET VALUE, BY APPLICATION, BY GEOGRAPHY, 2021-2027 (USD BILLION)

TABLE 6.           GLOBAL LIVE CELL IMAGING MARKET VALUE FOR CELL BIOLOGY, BY GEOGRAPHY, 2021-2027 (USD BILLION)

TABLE 7.           GLOBAL LIVE CELL IMAGING MARKET VALUE FOR DEVELOPMENTAL BIOLOGY, BY GEOGRAPHY, 2021-2027 (USD BILLION)

TABLE 8.           GLOBAL LIVE CELL IMAGING MARKET VALUE FOR STEM CELL & DRUG DISCOVERY, BY GEOGRAPHY, 2021-2027 (USD BILLION)

TABLE 9.           GLOBAL LIVE CELL IMAGING MARKET VALUE FOR OTHERS, BY GEOGRAPHY, 2021-2027 (USD BILLION)

TABLE 10.         GLOBAL LIVE CELL IMAGING MARKET VALUE, BY TECHNOLOGY, 2021-2027 (USD BILLION)

TABLE 11.         GLOBAL LIVE CELL IMAGING MARKET VALUE FOR TIME-LAPSE MICROSCOPY, BY GEOGRAPHY, 2021-2027 (USD BILLION)

TABLE 12.         GLOBAL LIVE CELL IMAGING MARKET VALUE FOR FLUORESCENCE RECOVERY AFTER PHOTOBLEACHING (FRAP), BY GEOGRAPHY, 2021-2027 (USD BILLION)

TABLE 13.         GLOBAL LIVE CELL IMAGING MARKET VALUE FOR FLUORESCENCE RESONANCE ENERGY TRANSFER (FRET), BY GEOGRAPHY, 2021-2027 (USD BILLION)

TABLE 14.         GLOBAL LIVE CELL IMAGING MARKET VALUE FOR HIGH CONTENT SCREENING (HCS), BY GEOGRAPHY, 2021-2027 (USD BILLION)

TABLE 15.         GLOBAL LIVE CELL IMAGING MARKET VALUE FOR OTHERS, BY GEOGRAPHY, 2021-2027 (USD BILLION)

TABLE 16.         NORTH AMERICA LIVE CELL IMAGING MARKET VALUE, BY COUNTRY, 2021-2027 (USD BILLION)

TABLE 17.         NORTH AMERICA LIVE CELL IMAGING MARKET VALUE, BY PRODUCT, 2021-2027 (USD BILLION)

TABLE 18.         NORTH AMERICA LIVE CELL IMAGING MARKET VALUE, BY APPLICATION, 2021-2027 (USD BILLION)

TABLE 19.         NORTH AMERICA LIVE CELL IMAGING MARKET VALUE, BY TECHNOLOGY, 2021-2027 (USD BILLION)

TABLE 20.         U.S LIVE CELL IMAGING MARKET VALUE, BY PRODUCT, 2021-2027 (USD BILLION)

TABLE 21.         U.S LIVE CELL IMAGING MARKET VALUE, BY APPLICATION, 2021-2027 (USD BILLION)

TABLE 22.         U.S LIVE CELL IMAGING MARKET VALUE, BY TECHNOLOGY, 2021-2027 (USD BILLION)

TABLE 23.         CANADA LIVE CELL IMAGING MARKET VALUE, BY PRODUCT, 2021-2027 (USD BILLION)

TABLE 24.         CANADA LIVE CELL IMAGING MARKET VALUE, BY APPLICATION, 2021-2027 (USD BILLION)

TABLE 25.         CANADA LIVE CELL IMAGING MARKET VALUE, BY TECHNOLOGY, 2021-2027 (USD BILLION)

TABLE 26.         EUROPE LIVE CELL IMAGING MARKET VALUE, BY COUNTRY, 2021-2027 (USD BILLION)

TABLE 27.         EUROPE LIVE CELL IMAGING MARKET VALUE, BY PRODUCT, 2021-2027 (USD BILLION)

TABLE 28.         EUROPE LIVE CELL IMAGING MARKET VALUE, BY APPLICATION, 2021-2027 (USD BILLION)

TABLE 29.         EUROPE LIVE CELL IMAGING MARKET VALUE, TECHNOLOGY, 2021-2027 (USD BILLION)

TABLE 30.         GERMANY LIVE CELL IMAGING MARKET VALUE, BY PRODUCT, 2021-2027 (USD BILLION)

TABLE 31.         GERMANY LIVE CELL IMAGING MARKET VALUE, BY APPLICATION, 2021-2027 (USD BILLION)

TABLE 32.         GERMANY LIVE CELL IMAGING MARKET VALUE, BY TECHNOLOGY, 2021-2027 (USD BILLION)

TABLE 33.         U.K LIVE CELL IMAGING  MARKET VALUE, BY PRODUCT, 2021-2027 (USD BILLION)

TABLE 34.         U.K LIVE CELL IMAGING MARKET VALUE, BY APPLICATION, 2021-2027 (USD BILLION)

TABLE 35.         U.K LIVE CELL IMAGING MARKET VALUE, BY TECHNOLOGY, 2021-2027 (USD BILLION)

TABLE 36.         FRANCE LIVE CELL IMAGING MARKET VALUE, BY PRODUCT, 2021-2027 (USD BILLION)

TABLE 37.         FRANCE LIVE CELL IMAGING MARKET VALUE, BY APPLICATION, 2021-2027 (USD BILLION)

TABLE 38.         FRANCE LIVE CELL IMAGING MARKET VALUE, BY TECHNOLOGY, 2021-2027 (USD BILLION)

TABLE 39.         ITALY LIVE CELL IMAGING MARKET VALUE, BY PRODUCT, 2021-2027 (USD BILLION)

TABLE 40.         ITALY LIVE CELL IMAGING MARKET VALUE, BY APPLICATION, 2021-2027 (USD BILLION)

TABLE 41.         ITALY LIVE CELL IMAGING MARKET VALUE, BY TECHNOLOGY, 2021-2027 (USD BILLION)

TABLE 42.         SPAIN LIVE CELL IMAGING MARKET VALUE, BY PRODUCT, 2021-2027 (USD BILLION)

TABLE 43.         SPAIN LIVE CELL IMAGING MARKET VALUE, BY APPLICATION, 2021-2027 (USD BILLION)

TABLE 44.         SPAIN LIVE CELL IMAGING MARKET VALUE, BY TECHNOLOGY, 2021-2027 (USD BILLION)

TABLE 45.         ROE LIVE CELL IMAGING MARKET VALUE, BY PRODUCT, 2021-2027 (USD BILLION)

TABLE 46.         ROE LIVE CELL IMAGING MARKET VALUE, BY APPLICATION, 2021-2027 (USD BILLION)

TABLE 47.         ROE LIVE CELL IMAGING MARKET VALUE, BY TECHNOLOGY, 2021-2027 (USD BILLION)

TABLE 48.         ASIA PACIFIC LIVE CELL IMAGING MARKET VALUE, BY COUNTRY, 2021-2027 (USD BILLION)

TABLE 49.         ASIA PACIFIC LIVE CELL IMAGING MARKET VALUE, BY PRODUCT, 2021-2027 (USD BILLION)

TABLE 50.         ASIA PACIFIC LIVE CELL IMAGING MARKET VALUE, BY APPLICATION, 2021-2027 (USD BILLION)

TABLE 51.         ASIA PACIFIC LIVE CELL IMAGING MARKET VALUE, BY TECHNOLOGY, 2021-2027 (USD BILLION)

TABLE 52.         CHINA LIVE CELL IMAGING MARKET VALUE, BY PRODUCT, 2021-2027 (USD BILLION)

TABLE 53.         CHINA LIVE CELL IMAGING MARKET VALUE, BY APPLICATION, 2021-2027 (USD BILLION)

TABLE 54.         CHINA LIVE CELL IMAGING MARKET VALUE, BY TECHNOLOGY, 2021-2027 (USD BILLION)

TABLE 55.         INDIA LIVE CELL IMAGING MARKET VALUE, BY PRODUCT, 2021-2027 (USD BILLION)

TABLE 56.         INDIA LIVE CELL IMAGING MARKET VALUE, BY APPLICATION, 2021-2027 (USD BILLION)

TABLE 57.         INDIA LIVE CELL IMAGING MARKET VALUE, BY TECHNOLOGY, 2021-2027 (USD BILLION)

TABLE 58.         JAPAN LIVE CELL IMAGING MARKET VALUE, BY PRODUCT, 2021-2027 (USD BILLION)

TABLE 59.         JAPAN LIVE CELL IMAGING MARKET VALUE, BY APPLICATION, 2021-2027 (USD BILLION)

TABLE 60.         JAPAN LIVE CELL IMAGING MARKET VALUE, BY TECHNOLOGY, 2021-2027 (USD BILLION)

TABLE 61.         REST OF APAC LIVE CELL IMAGING MARKET VALUE, BY PRODUCT, 2021-2027 (USD BILLION)

TABLE 62.         REST OF APAC LIVE CELL IMAGING MARKET VALUE, BY APPLICATION, 2021-2027 (USD BILLION)

TABLE 63.         REST OF APAC LIVE CELL IMAGING MARKET VALUE, BY TECHNOLOGY, 2021-2027 (USD BILLION)

TABLE 64.         REST OF WORLD LIVE CELL IMAGING MARKET VALUE, BY PRODUCT, 2021-2027 (USD BILLION)

TABLE 65.         REST OF WORLD LIVE CELL IMAGING MARKET VALUE, BY APPLICATION, 2021-2027 (USD BILLION)

TABLE 66.         REST OF WORLD LIVE CELL IMAGING MARKET VALUE, BY TECHNOLOGY, 2021-2027 (USD BILLION)

TABLE 67.         THERMO FISHER SCIENTIFIC INC: FINANCIALS

TABLE 68.         THERMO FISHER SCIENTIFIC INC: PRODUCTS & SERVICES      

TABLE 69.         THERMO FISHER SCIENTIFIC INC: RECENT DEVELOPMENTS    

TABLE 70.         NIKON INSTRUMENTS INC: FINANCIALS          

TABLE 71.         NIKON INSTRUMENTS INC: PRODUCTS & SERVICES    

TABLE 72.         NIKON INSTRUMENTS INC: RECENT DEVELOPMENTS   

TABLE 73.         MOLECULAR DEVICES, LLC: FINANCIALS         

TABLE 74.         MOLECULAR DEVICES, LLC: PRODUCTS & SERVICES    

TABLE 75.         MOLECULAR DEVICES, LLC: RECENT DEVELOPMENTS  

TABLE 76.         BIOTEK INSTRUMENTS, INC: FINANCIALS        

TABLE 77.         BIOTEK INSTRUMENTS, INC: PRODUCTS & SERVICES  

TABLE 78.         BIOTEK INSTRUMENTS, INC: RECENT DEVELOPMENTS

TABLE 79.         PERKINELMER INC: FINANCIALS          

TABLE 80.         PERKINELMER INC: PRODUCTS & SERVICES    

TABLE 81.         PERKINELMER INC: RECENT DEVELOPMENTS   

TABLE 82.         BRUKER CORPORATION: FINANCIALS  

TABLE 83.         BRUKER CORPORATION: PRODUCTS & SERVICES        

TABLE 84.         BRUKER CORPORATION: RECENT DEVELOPMENTS       

TABLE 85.         GENERAL ELECTRIC: FINANCIALS        

TABLE 86.         GENERAL ELECTRIC: PRODUCTS & SERVICES  

TABLE 87.         GENERAL ELECTRIC: RECENT DEVELOPMENTS 

TABLE 88.         OLYMPUS CORPORATION: FINANCIALS

TABLE 89.         OLYMPUS CORPORATION: PRODUCTS & SERVICES      

TABLE 90.         OLYMPUS CORPORATION: RECENT DEVELOPMENTS     

TABLE 91.         CYTOSKELETON, INC: FINANCIALS      

TABLE 92.         CYTOSKELETON, INC: PRODUCTS & SERVICES

TABLE 93.         CYTOSKELETON, INC: RECENT DEVELOPMENTS           

TABLE 94.         MERCK KGAA: FINANCIALS      

TABLE 95.         MERCK KGAA: PRODUCTS & SERVICES

TABLE 96.         MERCK KGAA: RECENT DEVELOPMENTS